アジェンダ
1:30 PM — 5:00 PM
Course 2: Innovation in Rx-to-OTC Switch8:00 AM — 9:00 AM
9:00 AM — 9:15 AM
Welcome and Opening Remarks9:15 AM — 10:00 AM
Session 1: Keynote Address10:00 AM — 10:30 AM
12:15 PM — 1:30 PM
1:30 PM — 3:00 PM
Session 3 Track A: Regulatory Processes – Innovations1:30 PM — 3:00 PM
Session 3 Track B: Regulatory Operations1:30 PM — 3:00 PM
Session 3 Track C: Science and Product Development3:00 PM — 3:30 PM
3:30 PM — 5:00 PM
Session 4 Track A: Enhancing Innovation3:30 PM — 5:00 PM
Session 4 Track B: New Digital Solutions for Canadian Product Monograph3:30 PM — 5:00 PM
Session 4 Track C: Personalized Medicine7:30 AM — 8:30 AM
8:30 AM — 10:00 AM
Session 5 Track A: Transparency and Openness8:30 AM — 10:00 AM
Session 5 Track B: Data/Analytics8:30 AM — 10:00 AM
Session 5 Track C: Generics and Biosimilars10:00 AM — 10:30 AM
10:30 AM — 12:00 PM
Session 6 Track A: Policy Development and Direction10:30 AM — 12:00 PM
Session 6 Track C: Risk Assessment and Risk Management12:00 PM — 1:30 PM